Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Tirzepatide: a new low for bodyweight and blood glucose The Lancet Diabetes & Endocrinology Unlocking the Power of Cagrilintide: A Deep Dive Into Dosage Schedules and What to Expect Feast Unveiling the Therapeutic Potential of the Second Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults